ID   PRAG1_RAT               Reviewed;        1368 AA.
AC   D3ZMK9;
DT   18-JUL-2018, integrated into UniProtKB/Swiss-Prot.
DT   20-APR-2010, sequence version 1.
DT   24-JUL-2024, entry version 99.
DE   RecName: Full=Inactive tyrosine-protein kinase PRAG1 {ECO:0000305};
DE   AltName: Full=PEAK1-related kinase-activating pseudokinase 1;
DE   AltName: Full=Pragma of Rnd2 {ECO:0000303|PubMed:16481321};
GN   Name=Prag1 {ECO:0000312|RGD:1311793};
GN   Synonyms=Pragmin {ECO:0000303|PubMed:16481321};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   TISSUE SPECIFICITY, FUNCTION, AND INTERACTION WITH RND2.
RX   PubMed=16481321; DOI=10.1074/jbc.m511314200;
RA   Tanaka H., Katoh H., Negishi M.;
RT   "Pragmin, a novel effector of Rnd2 GTPase, stimulates RhoA activity.";
RL   J. Biol. Chem. 281:10355-10364(2006).
RN   [4]
RP   SUBCELLULAR LOCATION, PHOSPHORYLATION AT TYR-391, MUTAGENESIS OF TYR-391,
RP   AND INTERACTION WITH CSK.
RX   PubMed=21873224; DOI=10.1073/pnas.1107740108;
RA   Safari F., Murata-Kamiya N., Saito Y., Hatakeyama M.;
RT   "Mammalian Pragmin regulates Src family kinases via the Glu-Pro-Ile-Tyr-Ala
RT   (EPIYA) motif that is exploited by bacterial effectors.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:14938-14943(2011).
RN   [5]
RP   INTERACTION WITH CSK, PHOSPHORYLATION AT TYR-391; TYR-238 AND TYR-343,
RP   SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=27116701; DOI=10.1111/cas.12962;
RA   Senda Y., Murata-Kamiya N., Hatakeyama M.;
RT   "C-terminal Src kinase-mediated EPIYA phosphorylation of Pragmin creates a
RT   feed-forward C-terminal Src kinase activation loop that promotes cell
RT   motility.";
RL   Cancer Sci. 107:972-980(2016).
RN   [6] {ECO:0007744|PubMed:22673903}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [7] {ECO:0007744|PDB:6EWX}
RP   X-RAY CRYSTALLOGRAPHY (2.77 ANGSTROMS) OF 906-1368, MUTAGENESIS OF TYR-391;
RP   LEU-939; ASP-978; TYR-981; LYS-997; GLN-1021; ALA-1329; TYR-1349 AND
RP   LEU-1362, SUBUNIT, INTERACTION WITH CSK, PHOSPHORYLATION AT TYR-391,
RP   DOMAIN, LACK OF ATP-BINDING, AND FUNCTION.
RX   PubMed=29503074; DOI=10.1016/j.str.2018.01.017;
RA   Lecointre C., Simon V., Kerneur C., Allemand F., Fournet A., Montarras I.,
RA   Pons J.L., Gelin M., Brignatz C., Urbach S., Labesse G., Roche S.;
RT   "Dimerization of the Pragmin pseudo-kinase regulates protein tyrosine
RT   phosphorylation.";
RL   Structure 26:545-554(2018).
CC   -!- FUNCTION: Catalytically inactive protein kinase that acts as a scaffold
CC       protein (PubMed:29503074). Functions as an effector of the small GTPase
CC       RND2, which stimulates RhoA activity and inhibits NGF-induced neurite
CC       outgrowth (PubMed:16481321). Promotes Src family kinase (SFK) signallig
CC       by regulating the subcellular localization of CSK, a negative regulator
CC       of these kinases, leading to the regulation of cell morphology and
CC       motility by a CSK-dependent mechanism (PubMed:21873224,
CC       PubMed:27116701). Acts as a critical coactivator of Notch signaling (By
CC       similarity). {ECO:0000250|UniProtKB:Q571I4,
CC       ECO:0000269|PubMed:16481321, ECO:0000269|PubMed:21873224,
CC       ECO:0000269|PubMed:27116701, ECO:0000269|PubMed:29503074}.
CC   -!- SUBUNIT: Homodimer (PubMed:29503074). Dimerization leads to the
CC       catalytic activation of CSK (PubMed:29503074). Interacts (via C-
CC       terminus) with RND2 (PubMed:16481321). Interacts with CSK (via SH2
CC       domain) in a Tyr-391 phosphorylation-dependent manner; this interaction
CC       potentiates kinase activity of CSK (PubMed:21873224, PubMed:27116701,
CC       PubMed:29503074). Interacts with NOTCH1 intracellular domain (N1ICD)
CC       (By similarity). Forms a complex with N1ICD and MAML1, in a MAML1-
CC       dependent manner (By similarity). {ECO:0000250|UniProtKB:Q571I4,
CC       ECO:0000269|PubMed:16481321, ECO:0000269|PubMed:21873224,
CC       ECO:0000269|PubMed:27116701, ECO:0000269|PubMed:29503074}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:21873224,
CC       ECO:0000269|PubMed:27116701}. Nucleus {ECO:0000250|UniProtKB:Q571I4}.
CC       Cell junction, focal adhesion {ECO:0000269|PubMed:27116701}.
CC       Note=Colocalized with NOTCH1 in the nucleus.
CC       {ECO:0000250|UniProtKB:Q571I4}.
CC   -!- TISSUE SPECIFICITY: Highly-expressed in brain, including cortical and
CC       hippocampal pyramidal neurons, as well as in kidney, spleen, colon and
CC       small intestine (PubMed:16481321). {ECO:0000269|PubMed:16481321}.
CC   -!- DOMAIN: The dimerization region encompasses helices both from the
CC       N- and C-terminal of the protein kinase domain.
CC       {ECO:0000269|PubMed:29503074}.
CC   -!- PTM: Phosphorylated by CSK on Tyr-238, Tyr-343, and Tyr-391; Tyr-391 is
CC       a primary site of phosphorylation. {ECO:0000269|PubMed:27116701}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. {ECO:0000305}.
CC   -!- CAUTION: Despite of the presence of a putative ATP-binding motif, this
CC       protein does not bind ATP, suggesting that it has no protein kinase
CC       activity (PubMed:29503074). {ECO:0000269|PubMed:29503074}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AABR07026025; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR07026026; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH473970; EDM09203.1; -; Genomic_DNA.
DR   RefSeq; NP_001100785.1; NM_001107315.1.
DR   RefSeq; XP_017455620.1; XM_017600131.1.
DR   RefSeq; XP_017455621.1; XM_017600132.1.
DR   PDB; 6EWX; X-ray; 2.77 A; A/B=906-1368.
DR   PDBsum; 6EWX; -.
DR   AlphaFoldDB; D3ZMK9; -.
DR   SMR; D3ZMK9; -.
DR   ELM; D3ZMK9; -.
DR   IntAct; D3ZMK9; 2.
DR   STRING; 10116.ENSRNOP00000015166; -.
DR   iPTMnet; D3ZMK9; -.
DR   PhosphoSitePlus; D3ZMK9; -.
DR   PaxDb; 10116-ENSRNOP00000015166; -.
DR   Ensembl; ENSRNOT00000015166.7; ENSRNOP00000015166.5; ENSRNOG00000011407.7.
DR   GeneID; 306506; -.
DR   KEGG; rno:306506; -.
DR   AGR; RGD:1311793; -.
DR   CTD; 157285; -.
DR   RGD; 1311793; Prag1.
DR   eggNOG; ENOG502QVUZ; Eukaryota.
DR   GeneTree; ENSGT00940000157066; -.
DR   HOGENOM; CLU_005467_0_0_1; -.
DR   InParanoid; D3ZMK9; -.
DR   OMA; DLKMSAC; -.
DR   OrthoDB; 2914135at2759; -.
DR   PhylomeDB; D3ZMK9; -.
DR   TreeFam; TF331193; -.
DR   Reactome; R-RNO-9696270; RND2 GTPase cycle.
DR   PRO; PR:D3ZMK9; -.
DR   Proteomes; UP000002494; Chromosome 16.
DR   Proteomes; UP000234681; Chromosome 16.
DR   Bgee; ENSRNOG00000011407; Expressed in cerebellum and 18 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IMP:UniProtKB.
DR   GO; GO:0004672; F:protein kinase activity; IBA:GO_Central.
DR   GO; GO:0016477; P:cell migration; ISO:RGD.
DR   GO; GO:0010977; P:negative regulation of neuron projection development; IMP:UniProtKB.
DR   GO; GO:0035025; P:positive regulation of Rho protein signal transduction; IMP:UniProtKB.
DR   GO; GO:2000145; P:regulation of cell motility; IMP:UniProtKB.
DR   GO; GO:0008360; P:regulation of cell shape; IMP:UniProtKB.
DR   GO; GO:0008593; P:regulation of Notch signaling pathway; ISS:UniProtKB.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR051511; MitoQC_Scaffold_Kinases.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   PANTHER; PTHR22972:SF3; INACTIVE TYROSINE-PROTEIN KINASE PRAG1; 1.
DR   PANTHER; PTHR22972; SERINE/THREONINE PROTEIN KINASE; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell junction; Cytoplasm; Nucleus; Phosphoprotein;
KW   Reference proteome.
FT   CHAIN           1..1368
FT                   /note="Inactive tyrosine-protein kinase PRAG1"
FT                   /id="PRO_0000444634"
FT   DOMAIN          940..1291
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          200..236
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          297..330
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          392..443
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          499..605
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          636..792
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          799..818
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          873..901
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          906..949
FT                   /note="Required for homodimerization"
FT                   /evidence="ECO:0000269|PubMed:29503074"
FT   REGION          1134..1166
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1293..1368
FT                   /note="Required for homodimerization"
FT                   /evidence="ECO:0000269|PubMed:29503074"
FT   COMPBIAS        311..330
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        392..406
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        411..443
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        542..575
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        652..666
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        701..754
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        877..901
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1134..1156
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         238
FT                   /note="Phosphotyrosine; by CSK"
FT                   /evidence="ECO:0000269|PubMed:27116701"
FT   MOD_RES         343
FT                   /note="Phosphotyrosine; by CSK"
FT                   /evidence="ECO:0000269|PubMed:27116701"
FT   MOD_RES         391
FT                   /note="Phosphotyrosine; by CSK"
FT                   /evidence="ECO:0000269|PubMed:21873224,
FT                   ECO:0000269|PubMed:27116701, ECO:0000269|PubMed:29503074"
FT   MOD_RES         667
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q86YV5"
FT   MOD_RES         716
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q86YV5"
FT   MOD_RES         753
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q86YV5"
FT   MOD_RES         797
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q86YV5"
FT   MUTAGEN         391
FT                   /note="Y->A: Does not affect cytoplasmic localization."
FT                   /evidence="ECO:0000269|PubMed:21873224"
FT   MUTAGEN         391
FT                   /note="Y->F: Decreases the interaction with CSK."
FT                   /evidence="ECO:0000269|PubMed:21873224,
FT                   ECO:0000269|PubMed:29503074"
FT   MUTAGEN         939
FT                   /note="L->E: Does not affect homodimerization."
FT                   /evidence="ECO:0000269|PubMed:29503074"
FT   MUTAGEN         978
FT                   /note="D->N: No ATP-binding activity."
FT                   /evidence="ECO:0000269|PubMed:29503074"
FT   MUTAGEN         981
FT                   /note="Y->F: No ATP-binding activity."
FT                   /evidence="ECO:0000269|PubMed:29503074"
FT   MUTAGEN         997
FT                   /note="K->A: Does not affect PRAG1-CSK complex formation.
FT                   Does not affect PRAG1-induced protein tyrosine
FT                   phosphorylation."
FT                   /evidence="ECO:0000269|PubMed:29503074"
FT   MUTAGEN         1021
FT                   /note="Q->E: No ATP-binding activity."
FT                   /evidence="ECO:0000269|PubMed:29503074"
FT   MUTAGEN         1329
FT                   /note="A->E: Strong reduction of homodimerization; Does not
FT                   affect PRAG1-CSK complex formation. Reduces CSK
FT                   activation."
FT                   /evidence="ECO:0000269|PubMed:29503074"
FT   MUTAGEN         1349
FT                   /note="Y->E: Does not affect homodimerization."
FT                   /evidence="ECO:0000269|PubMed:29503074"
FT   MUTAGEN         1362
FT                   /note="L->E: Does not affect homodimerization."
FT                   /evidence="ECO:0000269|PubMed:29503074"
FT   HELIX           921..946
FT                   /evidence="ECO:0007829|PDB:6EWX"
FT   HELIX           962..964
FT                   /evidence="ECO:0007829|PDB:6EWX"
FT   STRAND          965..967
FT                   /evidence="ECO:0007829|PDB:6EWX"
FT   STRAND          977..989
FT                   /evidence="ECO:0007829|PDB:6EWX"
FT   STRAND          994..999
FT                   /evidence="ECO:0007829|PDB:6EWX"
FT   STRAND          1026..1031
FT                   /evidence="ECO:0007829|PDB:6EWX"
FT   HELIX           1033..1035
FT                   /evidence="ECO:0007829|PDB:6EWX"
FT   STRAND          1059..1068
FT                   /evidence="ECO:0007829|PDB:6EWX"
FT   STRAND          1070..1073
FT                   /evidence="ECO:0007829|PDB:6EWX"
FT   HELIX           1074..1080
FT                   /evidence="ECO:0007829|PDB:6EWX"
FT   HELIX           1082..1087
FT                   /evidence="ECO:0007829|PDB:6EWX"
FT   HELIX           1089..1112
FT                   /evidence="ECO:0007829|PDB:6EWX"
FT   STRAND          1124..1128
FT                   /evidence="ECO:0007829|PDB:6EWX"
FT   STRAND          1173..1176
FT                   /evidence="ECO:0007829|PDB:6EWX"
FT   HELIX           1203..1206
FT                   /evidence="ECO:0007829|PDB:6EWX"
FT   HELIX           1209..1211
FT                   /evidence="ECO:0007829|PDB:6EWX"
FT   HELIX           1214..1226
FT                   /evidence="ECO:0007829|PDB:6EWX"
FT   HELIX           1258..1269
FT                   /evidence="ECO:0007829|PDB:6EWX"
FT   TURN            1274..1276
FT                   /evidence="ECO:0007829|PDB:6EWX"
FT   HELIX           1280..1292
FT                   /evidence="ECO:0007829|PDB:6EWX"
FT   HELIX           1296..1300
FT                   /evidence="ECO:0007829|PDB:6EWX"
FT   HELIX           1306..1332
FT                   /evidence="ECO:0007829|PDB:6EWX"
FT   HELIX           1341..1352
FT                   /evidence="ECO:0007829|PDB:6EWX"
FT   HELIX           1355..1364
FT                   /evidence="ECO:0007829|PDB:6EWX"
SQ   SEQUENCE   1368 AA;  147716 MW;  31BF773387FD28B7 CRC64;
     MSACSDFVEH IWKPGSCKNC FCLRSDHQLT AGHPKARASS LPAGARLPAR PEICRLEDEG
     VNGLAYSKPT IAVKPTMMTS ETADLWTEAS LSAEVPKVNW RRTPGKLLLQ KQEDGPIVYL
     GSFRGMQKAA GPLACTDSNS RCPPAYTMVG LHNLEARVDR NTALQPVNFQ EEKAGREELP
     SAQESFRQKL AAFTGMTSSC LKGPRPCTSP QPLRESLPSE DDSDQRCSPS GDSEGGEYCS
     ILDCRPESRD AVHNTEGSGR RRGDCSPICW EQGTCTRPTE EEKQALNFPR ECCGQGSTAN
     PPHLGPKKPS LNSEAASSSD GLSCGSSRSG ANSPFAPHLE NDYCSLVKEP TSVKQQDSGC
     HLVNSGKYVG QAVDLQPPAL PREAVQPEPI YAESAKRKKA APVPQRPEPK KEQVSSGQVW
     TGDTWSQKTP SGWSQEREGP NAAPQVATTI TVIAAHPEED HRTIYLSSPD SAVGVQWPRG
     SLNQDLHGSG EEPLVVQGLS SRESHPHNMT ENSSKEKPAI PPKLSKSSPG GSPVSPAAPP
     LTDHSDGNTS GSSVGSQPSS RVPTNLTSSC QTNGVAAGDP AKCPPQANSS VLDQRRPRYQ
     TGAWSRQCRI EEEEEVGQEL LSQSWGRELE NGIADHSNSS TWHRLHPIDG ASGQNGKTNS
     GMSKSASFAF EFPKDRGRLE SFSPPPPPPK SRHLLKMNKS SSDLEKVSQS SAESLSPSFR
     GAHVSFTTGS TDSLASDSRT CSDGGPSCEA THSPTISGKK LFAPVPFPSG STEDVSPSGP
     AQPPPLPQKK IVSRAASSPD GFFWTQGSPK PRTASPKLNL SHSETNVCAH DEPPLSYSLN
     SGNHPHHVFS SSEPLEKAFK GSVPWAPALG PANSKGGCGS PNLQGRAATS TSSSQLSVSS
     QASTGSSQLQ LHSLLSSISS KEGTYAKLGG LYTQSLARLV TKCEDLFMGG LKTELRFDEN
     SWSLFKLICN KPCCDSGDAI YYGATCSKDP DSIYAVKICK TPEPKSASYC SPSVPVHFNI
     QQDCGHFVAS VPSSMLAFPD TSSKDPAPAA PSHTPAQEQD CVVVITREVP HQTASDFVRD
     SVASHRAEPE VYERRVCFLL LQLCNGLEHL KEHGIIHRDL CLENLLLVHC NPQSSPGPSA
     NPSVPTTTSR CPSAAPAATT ACQGGPGEKH LPRLIISNFL KAKQKPGGTT NLQQKKSQAR
     LAPEIVSASQ YRKFDEFQTG ILIYELLHQP NPFEVRAQLR ERDYRREDLP PLPTLSLYSP
     GLQQLAHLLL EADPIKRIRI GEAKRVLQCL LWGPRRELVE QPCPSEEVLC NTLHNWIDMK
     RALMMMKFAE KAVERRRGVE LEDWLCCQYL ASAEPGALLQ SLKLLQLL
//
